BD Reports Q1 Sales Drop of 1 Percent; Acquires Accuri Cytometers

BD cited an unfavorable comparison to last year's sales of products related to the pandemic flu outbreak, as well as US stimulus-related revenue, as reasons for the decline. It also said it will acquire Accuri Cytometers for an undisclosed amount.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories